A carregar...
Publicação
Probing the microbiome to predict response to biologic therapy in Inflammatory Bowel Disease: one step closer to precision medicine?
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 74.73 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Current treatment algorithms in inflammatory bowel disease (IBD) rely on a “trial and error” approach, and therefore, patients may receive ineffective and costly therapy for many months, with associated risks. Furthermore, after failure of the first biologic, response rates to second-line therapies drop considerably. Personalized medicine, which seeks to identify biomarkers that predict disease course and treatment efficacy,
thus remains a significant unmet need in IBD.
Descrição
© 2022 by the AGA Institute
Palavras-chave
Contexto Educativo
Citação
Gastroenterology. 2022 Jun;162(7):2120-2122
Editora
Elsevier